• 1. 470. Thiocyanogen chloride. Part IV. Reaction with aromatic hydrocarbons; heterolytic and homolytic substitution in benzene homologues
  R. G. R. Bacon,R. G. Guy J. Chem. Soc. 1961 2428

Recent Advances in the Study of 3-Methylbenzyl Thiocyanate (CAS: 37141-50-7): A Comprehensive Research Brief

3-Methylbenzyl Thiocyanate (CAS: 37141-50-7) is an organosulfur compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique chemical properties and potential therapeutic applications. Recent studies have explored its role as a versatile building block in organic synthesis, as well as its biological activities, including antimicrobial, anticancer, and anti-inflammatory effects. This research brief aims to provide a comprehensive overview of the latest findings related to this compound, highlighting its synthetic utility, mechanism of action, and potential applications in drug discovery.

One of the most notable advancements in the study of 3-Methylbenzyl Thiocyanate is its application in the synthesis of biologically active molecules. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility as a precursor in the development of novel thiocyanate-containing derivatives with enhanced antimicrobial properties. The researchers employed a combination of computational modeling and experimental validation to identify key structural features that contribute to the compound's bioactivity. Their findings suggest that the thiocyanate moiety plays a critical role in disrupting bacterial cell membranes, making it a promising candidate for the development of new antibiotics.

In addition to its antimicrobial potential, 3-Methylbenzyl Thiocyanate has also been investigated for its anticancer properties. A recent study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of this compound exhibit selective cytotoxicity against certain cancer cell lines, particularly those associated with breast and lung cancers. The study utilized in vitro assays to evaluate the compound's ability to induce apoptosis and inhibit cell proliferation. The results indicated that the compound's mechanism of action involves the modulation of key signaling pathways, such as the PI3K/AKT and MAPK pathways, which are often dysregulated in cancer cells.

Another area of interest is the compound's potential anti-inflammatory effects. A 2022 study published in European Journal of Pharmacology explored the role of 3-Methylbenzyl Thiocyanate in mitigating inflammation-related disorders. The researchers conducted in vivo experiments using murine models of acute and chronic inflammation, demonstrating that the compound significantly reduced the production of pro-inflammatory cytokines, such as TNF-α and IL-6. These findings suggest that 3-Methylbenzyl Thiocyanate could serve as a lead compound for the development of new anti-inflammatory drugs.

Despite these promising findings, challenges remain in the clinical translation of 3-Methylbenzyl Thiocyanate and its derivatives. Issues such as bioavailability, toxicity, and pharmacokinetic properties need to be addressed through further preclinical and clinical studies. However, the compound's versatility and demonstrated biological activities make it a valuable subject of ongoing research in the chemical biology and medicinal chemistry communities.

In conclusion, recent studies on 3-Methylbenzyl Thiocyanate (CAS: 37141-50-7) have highlighted its potential as a multifunctional compound with applications in antimicrobial, anticancer, and anti-inflammatory therapies. Continued research efforts are expected to further elucidate its mechanisms of action and optimize its pharmacological properties, paving the way for its eventual use in clinical settings.

• 18991-39-4(Thiocyanic acid,(4-methylphenyl)methyl ester)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)